Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

564
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
564
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

717
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
717
Hazard Ratio01:12

Hazard Ratio

727
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
727
Blind Procedures02:07

Blind Procedures

13.9K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lifting the veil off treatment effect heterogeneity.

American heart journal·2024
Same author

Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?

Clinical trials (London, England)·2009
See all related articles

Related Experiment Video

Updated: Apr 10, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K

Post hoc subgroups in clinical trials: Anathema or analytics?

Herbert I Weisberg1, Victor P Pontes2

  • 1Causalytics, LLC, Needham, MA, USA hweisberg@causalytics.com.

Clinical Trials (London, England)
|June 12, 2015
PubMed
Summary

Predictive analytics offers a powerful alternative to traditional subgroup analyses for estimating individualized treatment effects. Cadit modeling, a novel approach, can identify patient subgroups with negligible adverse effects, enhancing treatment safety and efficacy.

Keywords:
Highly Accurate and Robust Variable Evaluation Selection and TestingRandomized Aldactone Evaluation StudySubgroupsadaptive signaturecaditpersonalized medicineprecision medicinepredictive analyticsspironolactone

Related Experiment Videos

Last Updated: Apr 10, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K

Area of Science:

  • Biostatistics
  • Clinical Trial Analysis
  • Predictive Analytics

Background:

  • Traditional statistical methods struggle with individualized treatment effect estimation.
  • Post hoc subgroup analyses in clinical trials present significant methodological challenges.
  • Predictive analytics offers an adaptable research paradigm for personalized medicine.

Purpose of the Study:

  • To compare statistical and analytics perspectives on treatment effect estimation.
  • To introduce cadit modeling as a method for identifying individualized causal effects.
  • To propose predictive modeling as a replacement for subgroup analysis.

Main Methods:

  • Comparative analysis of statistical and predictive modeling approaches.
  • Introduction of cadit modeling for individualized causal effect analysis.
  • Development of a novel variable-selection algorithm for cadit modeling.

Main Results:

  • Cadit modeling effectively identifies individualized causal effects, especially with numerous predictors.
  • Reanalysis of the Randomized Aldactone Evaluation Study demonstrated cadit's utility.
  • The approach predicted hyperkalemia risk and identified a subgroup with negligible effects.

Conclusions:

  • Cadit modeling presents a promising alternative to traditional subgroup analyses.
  • Cadit regression is user-friendly, yielding interpretable results.
  • The method integrates seamlessly with various variable-selection algorithms.